Farnesoid X receptor agonist INT-787 exhibits high intestinal localization

被引：0

作者：

Burkey, Jennifer ^{[1
]}

Kansra, Sanjay ^{[1
]}

Macchiarulo, Antonio ^{[2
]}

Brouwer, Kenneth ^{[3
]}

Adorini, Luciano ^{[1
]}

Erickson, Mary ^{[1
]}

Pellicciari, Roberto ^{[4
]}

机构：

[1] Intercept Pharmaceut Inc, Morristown, NJ USA

[2] Univ Perugia, Dept Pharmaceut Sci, Perugia, Italy

[3] BioIVT, ADME TOX Div, Chapel Hill, NC USA

[4] TES Pharma Srl, Perugia, Italy

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-316

引用

页码：S126 / S127

页数：2

共 50 条

[21] Multitarget Soluble Epoxide Hydrolase/Farnesoid X Receptor Agonist Combats CKD
Imig, John D.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 752 - 753
[22] INT 767-A NOVEL DUAL FARNESOID-X RECEPTOR (FXR) AND TAKEDA G-PROTEIN-COUPLED RECEPTOR-5 (TGR5) AGONIST ATTENUATES INTESTINAL ISCHEMIA REPERFUSION INJURY
Canovai, Emilio
Farre, Ricard
Accarie, Alison
De Hertogh, Gert
Vanuytsel, Tim
Pirenne, Jacques
Ceulemans, Laurens J.
TRANSPLANTATION, 2020, 104 (09) : S167 - S168
[23] Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal Maturation
Weber, Andre A.
Mennillo, Elvira
Yang, Xiaojing
van der Schoor, Lori W. E.
Jonker, Johan W.
Chen, Shujuan
Tukey, Robert H.
DRUG METABOLISM AND DISPOSITION, 2021, 49 (01) : 12 - 19
[24] Lepidozenolide from the liverwort Lepidozia fauriana acts as a farnesoid X receptor agonist
Lin, Hsiang-Ru
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2015, 17 (02) : 149 - 158
[25] Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice
Ikpa, Pauline T.
Doktorova, Marcela
Meijsen, Kelly F.
Nieuwenhuijze, Natascha D. A.
Verkade, Henkjan J.
Jonker, Johan W.
de Jonge, Hugo R.
Bijvelds, Marcel J. C.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2020, 9 (01): : 47 - 60
[26] Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice
de Boer, Jan Freark
Schonewille, Marleen
Boesjes, Marije
Wolters, Henk
Bloks, Vincent W.
Bos, Trijnie
van Dijk, Theo H.
Jurdzinski, Angelika
Boverhof, Renze
Wolters, Justina C.
Kuivenhoven, Jan A.
van Deursen, Jan M.
Elferink, Ronald P. J. Oude
Moschetta, Antonio
Kremoser, Claus
Verkade, Henkjan J.
Kuipers, Folkert
Groen, Albert K.
GASTROENTEROLOGY, 2017, 152 (05) : 1126 - +
[27] EDP-305, A SELECTIVE FARNESOID X RECEPTOR AGONIST, EXHIBITS EXCELLENT POTENCY IN VITRO AND IN VIVO AND ANTI-FIBROTIC EFFECT IN VITRO
Li, Yang
Chau, Mary
Or, Yat Sun
Jiang, Li-Juan
GASTROENTEROLOGY, 2018, 154 (06) : S1159 - S1159
[28] On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity
Kronenberger, Thales
Windshugel, Bjorn
Wrenger, Carsten
Honorio, Kathia M.
Maltarollo, Vinicius G.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (16): : 4378 - 4391
[29] Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study
Erken, Robin
Andre, Patrice
Roy, Elise
Kootstra, Neeltje
Barzic, Noelie
Girma, Hugo
Laveille, Christian
Radreau-Pierini, Pauline
Darteil, Raphael
Vonderscher, Jacky
Scalfaro, Pietro
Tangkijvanich, Pisit
Flisiak, Robert
Reesink, Henk
JOURNAL OF VIRAL HEPATITIS, 2021, 28 (12) : 1690 - 1698
[30] A leoligin derivative as farnesoid X receptor agonist and modulator of macrophage cholesterol efflux
Ladurner, A.
Wang, L.
Holzer, A.
Kovarova, L.
Linder, T.
Schuster, D.
Mihovilovic, M. D.
Atanasov, A. G.
Dirsch, V. M.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S35 - S35

← 1 2 3 4 5 →